HIV Infections: all 4,342 studies

Page 30 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.

• TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) PreviouslyTerminatedNCT00513513Phase 2
• Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*CompletedNCT00511368Phase 2
• Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral TherapyCompletedNCT00511056
• Kaletra Monotherapy in HIV/HCV Co-infected SubjectsCompletedNCT00508222Phase 3
• Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDSCompletedNCT00505401Phase 1
• Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ PatientsTerminatedNCT00504452Phase 2
• Biomarkers of Insomnia and Fatigue in HIV/AIDS (Symptoms and Genetics Study)CompletedNCT00503633
• Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency VirusCompletedNCT00503347Phase 1
• Smoking Cessation for HIV/AIDS PatientsCompletedNCT00502827Not applicable
• Therapeutic Schools: Affect Management and HIV PreventionCompletedNCT00500487Phase 1
• The Effect of Malaria on Disease Progression of HIV/AIDSCompletedNCT00499876Not applicable
• Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C VirusStatus unknownNCT00499434
• Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and AfricaWithdrawnNCT00498056Phase 2
• Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)CompletedNCT00495651Phase 3
• HIV Prevention in Haitian American AdolescentsCompletedNCT00494273Phase 1/2
• HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of BiomarkersCompletedNCT00491335
• Vitamin D Reabsorption in Adolescents and Young Adults With HIV InfectionCompletedNCT00490412Not applicable
• Microbicides Acceptability Among Sexually Active Young WomenCompletedNCT00490152
• Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy VolunteersCompletedNCT00490074Phase 1/2
• Growth Hormone in the Treatment of HIV-Associated WastingCompletedNCT00489528Phase 3
• An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected IndividualsCompletedNCT00489385Phase 1
• Engaging Care for HIV-infected Adolescent Females.CompletedNCT00489034
• Safety And Efficacy Study Of CP-675,206 In HIV-Infected PatientsWithdrawnNCT00488995Phase 2
• Effects of Creatine and Resistance Exercise Training in People With HIV InfectionCompletedNCT00484627Phase 2
• Project HERMITAGE: HIV Prevention in Hospitalized Russian DrinkersCompletedNCT00483483Not applicable
• A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV MedicationCompletedNCT00482963Phase 1
• Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV VaccineCompletedNCT00482027Phase 1
• Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected PatientsCompletedNCT00481390
• Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected PatientsCompletedNCT00480792Phase 3
• A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or BothCompletedNCT00480558Phase 1
• RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected PatientsStatus unknownNCT00480350Phase 2
• Phase 1 Safety Study of Two Experimental HIV VaccinesCompletedNCT00479999Phase 1
• A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, ChinaCompletedNCT00479141Not applicable
• Safety Study of IL-7 in HIV-infected Patients (Inspire)CompletedNCT00477321Phase 1
• Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIsCompletedNCT00477308Not applicable
• Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1CompletedNCT00476671
• A Prospective Cohort of Children With HIV InfectionCompletedNCT00476606
• Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/rCompletedNCT00476502
• A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected SubjectsCompletedNCT00476424Phase 2
• A PK and Salvage Study for Children With HIV-infectionCompletedNCT00476359Phase 4
• Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)CompletedNCT00474370Phase 3
• Behavioral, Clinical and Basic Science Studies of Non-occupational Post-exposure Prophylaxis ("PEP-2")CompletedNCT00473018Not applicable
• A Pharmacokinetic Study of Dapivirine Vaginal Rings in BelgiumCompletedNCT00469768Phase 1
• A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery MethodCompletedNCT00469170Early Phase 1
• LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)CompletedNCT00466258Phase 4
• Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected PatientsCompletedNCT00466180Phase 4
• HIV and Cardiovascular RiskCompletedNCT00465426
• HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsCompletedNCT00465205Phase 3
• ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.WithdrawnNCT00461266Phase 4
• Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant VirusesCompletedNCT00460382Phase 2
• CMV Disease and IRIS in HIV-1 Infected PersonsCompletedNCT00456664
• Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator ProductsCompletedNCT00455585Phase 4
• Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral LoadCompletedNCT00454337Phase 3
• Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701CompletedNCT00453440
• Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2Status unknownNCT00451984Phase 3
• Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected AdultsCompletedNCT00449436Phase 4
• Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack UsersCompletedNCT00447798Not applicable
• Effect of Atazanavir on Endothelial Function in HIV-Infected PatientsCompletedNCT00447070Phase 4
• Safety Study of UC-781 Vaginal MicrobicideCompletedNCT00446979Phase 1
• Trial of Zinc and HIV Progression in ChildrenCompletedNCT00446758Phase 3
• Computer Assisted Rx Education for HIV-Positives: CARE+CompletedNCT00443378Not applicable
• Phase I Study of Safety and Persistence of UC-781 Vaginal MicrobicideCompletedNCT00441909Phase 1
• Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected PatientsCompletedNCT00441688Phase 4
• Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIVCompletedNCT00441298Phase 2
• Multicenter Trial of Immunologic Markers to Predict Long Term Virologic OutcomesCompletedNCT00440206
• Lopinavir Capsules to Kaletra or Invirase TabletsCompletedNCT00438152Phase 4
• Randomized Controlled Trial of Stress Management Training in HIVCompletedNCT00436085Phase 3
• Pharmacogenetics of Antiretroviral DrugsCompletedNCT00435656
• Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load MonitoringCompletedNCT00434070
• Study of Pharmacokinetics in HIV-infected WomenCompletedNCT00433979
• Long Term Treatment InterruptionsCompletedNCT00433056Phase 3
• Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in ThailandCompletedNCT00433030
• A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease InhibitorCompletedNCT00432783
• Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIVCompletedNCT00432016Phase 1/2
• Effects of Anti-HIV Therapy on Nervous System FunctionCompletedNCT00432003
• Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)CompletedNCT00431548Not applicable
• Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized TrialCompletedNCT00429845Not applicable
• Effects of Treatment With Aprepitant (Emend®) in HIV Infected IndividualsCompletedNCT00428519Phase 1
• Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy AdultsCompletedNCT00428337Phase 1
• Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive MenCompletedNCT00428285Phase 2
• Assessment of Asymptomatic Heart Disease in Children With HIVStatus unknownNCT00426374Not applicable
• Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 PrimevaCompletedNCT00424814Phase 2/3
• Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136CompletedNCT00421551Phase 3
• Oral Human Papillomavirus Infection in HIV-infected MenStatus unknownNCT00421486
• Pharmacokinetic Study of Two HIV Protease Inhibitors in PatientsTerminatedNCT00420355Phase 4
• Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African AdultsWithdrawnNCT00415649Phase 2
• Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues OnlyCompletedNCT00415090Phase 4
• A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infectionWithdrawnNCT00414414Phase 3
• BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)TerminatedNCT00414284Phase 4
• Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African AdultsCompletedNCT00413725Phase 2
• A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 VaccineCompletedNCT00412477Phase 1
• Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected PatientsCompletedNCT00411957Phase 1/2
• Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in ThailandTerminatedNCT00409591Phase 3
• An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART)CompletedNCT00408642Phase 3
• Safety and Acceptability Study of the UC-781 Microbicide Gel Applied RectallyCompletedNCT00408538Phase 1
• Efficacy Study of T Cell Vaccination in HIV InfectionCompletedNCT00407836Phase 2
• Male Partner Involvement in the Prevention of MTCT of HIVCompletedNCT00405990Phase 4
• FREE Study: Efficacy and Toxicity of TrizivirCompletedNCT00405925Phase 3
• Safety Study of Elvucitabine in HIV-1 SubjectsCompletedNCT00405249Phase 2
• Dendritic Cell Vaccine in HIV-1 InfectionCompletedNCT00402142Phase 1/2

← HIV Infections overview